The US Food and Drug Administration has approved Google's Fitbit photoplethysmography (PPG) algorithm to identify atrial fibrillation (AFib). Google says the AFib detection feature will be coming soon ...

This morning Fitbit landed FDA clearance for its long-awaited photoplethysmography atrial fibrillation (AFib) detection algorithm. The algorithm will be part of Fitbit's new Irregular Heart Rhythm ...

Just a few months after Fitbit roped in FDA clearance for an algorithm that could be embedded into its eponymous health-tracking wearables to detect atrial fibrillation, the technology is ready to hit ...

"Our new PPG AFib algorithm can passively assess your heart rhythm in the background while you’re still or asleep. If there’s anything that might be suggestive of AFib, you’ll be notified through our ...

Two weeks back, Google announced that it was seeking U.S. Food and Drug Administration approval for a new atrial fibrillation-detecting technology it planned to roll out to Fibit wearables. Today, the ...

AFib is a type of irregular heart rhythm, it can be hard to detect due to a lack of visible and obvious symptoms, and later detection can increase stroke risk. Google said its AFib algorithm, ...

Just a few weeks after announcing its intentions, Fitbit and Google have today announced that clearance has been granted in the United States for select trackers and smartwatches to detect irregular ...

On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.

～米国初、心房細動の可能性を検出する血圧計としてFDAのDeNovo認可を取得～ オムロン ヘルスケア株式会社（本社所在地：京都府向日市、代表取締役社長:岡田 歩、以下当社）は、心電図を記録せずに血圧を測定するだけで不整脈の一種である心房細動の可能 ...